Marianne Pavel

Phase 3 Trial of ¹⁷⁷ Lu-Dotatate for Midgut Neuroendocrine Tumors

Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin et al. · New England Journal of Medicine · 2017 · 3.2K citations · Full text

Medicine, Oncology, Pharmacology +17

Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study

Cédric Nesti, Konstantin Bräutigam, Marta Benavent et al. · The Lancet Oncology · 2023 · 66 citations · Full text

Medicine, Oncology, Surgery +15

Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network ( <scp>United States</scp> ) and the prospective diabetes follow‐up (Germany/Austria) registries

Viral N. Shah, Julia M. Grimsmann, Nicole C. Foster et al. · Diabetes Obesity and Metabolism · 2020 · 60 citations

Medicine, Chronic Disease Control, Clinical Epidemiology +16

Radical Resection in Entero-Pancreatic Neuroendocrine Tumors: Recurrence-Free Survival Rate and Definition of a Risk Score for Recurrence

Elettra Merola, Andreas Pascher, Anja Rinke et al. · Annals of Surgical Oncology · 2022 · 12 citations · Full text

Medicine, Oncology, Surgery +17

Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4

Roberto Buzzoni, Carlo Carnaghi, Jonathan Strosberg et al. · OncoTargets and Therapy · 2017 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17